BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22220977)

  • 1. Paraneoplastic neurological and hematological syndromes associated with prostate cancer.
    Gakiya M; Naka H; Saito S
    Int J Urol; 2012 May; 19(5):471-4. PubMed ID: 22220977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral cancer-associated paraneoplastic syndromes.
    Feller L; Wood NH; Khammissa RA; Chikte UM; Essop R; Meyerov R; Lemmer J
    SADJ; 2010 Oct; 65(9):424-6. PubMed ID: 21180290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer-producing granulocyte colony-stimulating factor.
    Matsuoka Y; Arai G; Okada Y; Aida J
    Urol Int; 2009; 82(1):113-5. PubMed ID: 19172109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic production of granulocyte colony-stimulating factor in a bladder carcinoma.
    Turalic H; Deamant FD; Reese JH
    Scand J Urol Nephrol; 2006; 40(5):429-32. PubMed ID: 17060092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic syndrome of hypercalcemia and leukocytosis caused by squamous carcinoma cells (T3M-1) producing parathyroid hormone-related protein, interleukin 1 alpha, and granulocyte colony-stimulating factor.
    Sato K; Fujii Y; Kakiuchi T; Kasono K; Imamura H; Kondo Y; Mano H; Okabe T; Asano S; Takaku F
    Cancer Res; 1989 Sep; 49(17):4740-6. PubMed ID: 2474371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder carcinoma producing granulocyte colony-stimulating factor: a case report.
    Satoh H; Abe Y; Katoh Y; Komine Y; Nakamura M; Tamaoki N
    J Urol; 1993 Apr; 149(4):843-5. PubMed ID: 7681120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine leiomyosarcoma producing granulocyte colony stimulating factor.
    Nakayama K; Nakayama N; Rahman MT; Rahman M; Katagiri H; Katagiri A; Ishikawa M; Ishibashi T; Iida K; Harada Y; Miyazaki K
    Int J Gynecol Pathol; 2012 Mar; 31(2):172-177. PubMed ID: 22317876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic syndromes in cancer: Case 2. Leucocytosis associated with liposarcoma recurrence: original presentation of liposarcoma recurrence.
    des Guetz G; Mariani P; Freneaux P; Pouillart P
    J Clin Oncol; 2004 Jun; 22(11):2242-3. PubMed ID: 15169814
    [No Abstract]   [Full Text] [Related]  

  • 9. Small-cell carcinoma of the esophagus associated with a paraneoplastic neurological syndrome: a case report documenting a complete response.
    Shimoda T; Koizumi W; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Azuma M; Saigenji K; Katou T; Ogino M
    Jpn J Clin Oncol; 2006 Feb; 36(2):109-12. PubMed ID: 16517835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paraneoplastic neurological syndrome in 64-year-old patient in association with a small cell lung carcinoma].
    Prouzová Z; Brychtová S
    Klin Onkol; 2012; 25(6):471-5. PubMed ID: 23301652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholestatic Jaundice as a Paraneoplastic Manifestation of Prostate Cancer Aggravated by Steroid Therapy.
    Kang MK; Park JG; Lee HJ
    Med Princ Pract; 2018; 27(2):197-200. PubMed ID: 29320775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of biochemical recurrence of prostate cancer with granulocyte-macrophage colony-stimulating factor secreting, allogeneic, cellular immunotherapy.
    Urba WJ; Nemunaitis J; Marshall F; Smith DC; Hege KM; Ma J; Nguyen M; Small EJ
    J Urol; 2008 Nov; 180(5):2011-7; discussion 2017-8. PubMed ID: 18801509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Paraneoplastic syndromes in urology].
    Pérez Arbej JA; Nogueras Gimeno MA; Martínez Pérez E; Abad Menor F; Arnáiz Esteban F; Fernández Rosaénz J; Guinda Sevillano C; Espuela Orgaz R
    Arch Esp Urol; 1991 Oct; 44(8):943-9. PubMed ID: 1796856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunopathogenesis of paraneoplastic neurological syndromes.
    Sutton I; Winer JB
    Clin Sci (Lond); 2002 May; 102(5):475-86. PubMed ID: 11980564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.
    Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic cholestatic jaundice may be a paraneoplastic manifestation of underlying malignancy: a case of prostate cancer.
    Okano A; Ohana M; Kusumi F
    Clin J Gastroenterol; 2014 Jun; 7(3):278-82. PubMed ID: 26183750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory prostate cancer: an underestimated paraneoplastic clinical manifestation.
    Mauri D; Pentheroudakis G; Tolis C; Chojnacka M; Pavlidis N
    Urol Oncol; 2005; 23(5):318-22. PubMed ID: 16144664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Simultaneous production of parathyroid hormone-related protein (PTHrP) and granulocyte colony-stimulating factor (G-CSF) in lung cancer patients with hypercalcemia and leukocytosis].
    Sakamoto A; Katakami H; Mukae H; Taniguchi H; Maki H; Ashitani J; Ihi T; Dohtsu Y; Matsukura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jan; 33(1):34-8. PubMed ID: 7535368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A brainstem paraneoplastic syndrome associated with prostate cancer.
    Berger JR; Bensalem M; Dalmau J
    J Neurol Neurosurg Psychiatry; 2009 Aug; 80(8):934-5. PubMed ID: 19608787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Spinal cord paraneoplastic syndromes].
    Marés-Segura R
    Rev Neurol; 2000 Dec 16-31; 31(12):1219-23. PubMed ID: 11205563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.